{"id":"https://openalex.org/W7128370445","doi":"https://doi.org/10.1021/acs.jmedchem.5c03208","title":"Discovery and Optimization of Orally Bioavailable Heterobifunctional Degraders of KAT2A/B for the Treatment of Cancer","display_name":"Discovery and Optimization of Orally Bioavailable Heterobifunctional Degraders of KAT2A/B for the Treatment of Cancer","publication_year":2026,"publication_date":"2026-02-09","ids":{"openalex":"https://openalex.org/W7128370445","doi":"https://doi.org/10.1021/acs.jmedchem.5c03208","pmid":"https://pubmed.ncbi.nlm.nih.gov/41656736"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.5c03208","doi":"https://doi.org/10.1021/acs.jmedchem.5c03208","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.5c03208","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005315686","display_name":"James Neef","orcid":"https://orcid.org/0000-0002-1296-9703","observed_orcids":["https://orcid.org/0000-0002-1296-9703"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"James Neef","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":"https://orcid.org/0000-0002-1296-9703","affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050943295","display_name":"Kimberly S. Straley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly S. Straley","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125389280","display_name":"Chinmoy Mukherjee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800946588","display_name":"Industrial Credit and Investment Corporation of India","ror":"https://ror.org/05sfbd077","country_code":"IN","type":"other","lineage":["https://openalex.org/I2800946588"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Chinmoy Mukherjee","raw_affiliation_strings":["Medicinal Chemistry Department, Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078 Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry Department, Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078 Telangana, India","institution_ids":["https://openalex.org/I2800946588"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125408637","display_name":"Amol Tipnis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800946588","display_name":"Industrial Credit and Investment Corporation of India","ror":"https://ror.org/05sfbd077","country_code":"IN","type":"other","lineage":["https://openalex.org/I2800946588"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Amol Tipnis","raw_affiliation_strings":["Medicinal Chemistry Department, Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078 Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry Department, Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078 Telangana, India","institution_ids":["https://openalex.org/I2800946588"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048345882","display_name":"Suleman R. Maujan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800946588","display_name":"Industrial Credit and Investment Corporation of India","ror":"https://ror.org/05sfbd077","country_code":"IN","type":"other","lineage":["https://openalex.org/I2800946588"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Suleman Riyajsaheb Maujan","raw_affiliation_strings":["Medicinal Chemistry Department, Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078 Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry Department, Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078 Telangana, India","institution_ids":["https://openalex.org/I2800946588"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084967963","display_name":"Maulasri Bhatta","orcid":"https://orcid.org/0000-0001-8824-8884","observed_orcids":["https://orcid.org/0000-0001-8824-8884"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maulasri Bhatta","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020022960","display_name":"Sambad Sharma","orcid":"https://orcid.org/0000-0001-5184-8624","observed_orcids":["https://orcid.org/0000-0001-5184-8624"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sambad Sharma","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018374237","display_name":"Sara L. Sinicropi-Yao","orcid":"https://orcid.org/0000-0003-2730-4939","observed_orcids":["https://orcid.org/0000-0003-2730-4939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara Sinicropi-Yao","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010815947","display_name":"Joe DeBartolo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joe DeBartolo","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001354371","display_name":"Andrew J. McRiner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew J. McRiner","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Betty Chan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Betty Chan","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Henry Wilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henry Wilson","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christina S. Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina S. Lee","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107946357","display_name":"Zied Boudhraa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135858","display_name":"Paraza Pharma (Canada)","ror":"https://ror.org/03sg6z947","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210135858"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Zied Boudhraa","raw_affiliation_strings":["Paraza Pharma, Inc, 275 Boul. Armand-Frappier Laval, QC H7 V 4A Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paraza Pharma, Inc, 275 Boul. Armand-Frappier Laval, QC H7 V 4A Canada","institution_ids":["https://openalex.org/I4210135858"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019903925","display_name":"Mohamed El Ezzy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135858","display_name":"Paraza Pharma (Canada)","ror":"https://ror.org/03sg6z947","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210135858"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mohamed El Ezzy","raw_affiliation_strings":["Paraza Pharma, Inc, 275 Boul. Armand-Frappier Laval, QC H7 V 4A Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paraza Pharma, Inc, 275 Boul. Armand-Frappier Laval, QC H7 V 4A Canada","institution_ids":["https://openalex.org/I4210135858"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967795","display_name":"Mark A. Bittinger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Bittinger","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094223273","display_name":"Laura Antipov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Jennings Antipov","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022247782","display_name":"Thomas G. Graeber","orcid":"https://orcid.org/0000-0001-8574-9181","observed_orcids":["https://orcid.org/0000-0001-8574-9181"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas G. Graeber","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":"https://orcid.org/0000-0001-8574-9181","affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053897548","display_name":"Katharine E. Yen","orcid":"https://orcid.org/0000-0003-2054-9108","observed_orcids":["https://orcid.org/0000-0003-2054-9108"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katharine E. Yen","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018290375","display_name":"David S. Millan","orcid":"https://orcid.org/0000-0001-5590-7273","observed_orcids":["https://orcid.org/0000-0001-5590-7273"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David S. Millan","raw_affiliation_strings":["Auron Therapeutics"],"raw_orcid":"https://orcid.org/0000-0001-5590-7273","affiliations":[{"raw_affiliation_string":"Auron Therapeutics","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5005315686"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.06487436,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"69","issue":"4","first_page":"4548","last_page":"4566"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gcn5","display_name":"GCN5","score":0.9049999713897705},{"id":"https://openalex.org/keywords/kat2b","display_name":"KAT2B","score":0.9269999861717224},{"id":"https://openalex.org/keywords/heterobifunctional-degraders","display_name":"heterobifunctional degraders","score":0.9589999914169312},{"id":"https://openalex.org/keywords/protein-degradation","display_name":"protein degradation","score":0.4309999942779541},{"id":"https://openalex.org/keywords/histone-acetyltransferase","display_name":"histone acetyltransferase","score":0.921999990940094},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9570000171661377},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neuroendocrine-prostate-cancer","display_name":"neuroendocrine prostate cancer","score":0.9760000109672546},{"id":"https://openalex.org/keywords/neuroendocrine-carcinoma","display_name":"neuroendocrine carcinoma","score":0.8040000200271606},{"id":"https://openalex.org/keywords/tumor-plasticity","display_name":"tumor plasticity","score":0.8989999890327454},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8880000114440918}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6439999938011169},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6284999847412109},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5866000056266785},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5307999849319458},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.49239999055862427},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.48730000853538513},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4788999855518341},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.47530001401901245},{"id":"https://openalex.org/C2778001298","wikidata":"https://www.wikidata.org/wiki/Q1036906","display_name":"Histone acetyltransferase","level":4,"score":0.46380001306533813},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.41589999198913574},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.41510000824928284},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.37560001015663147},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3668999969959259},{"id":"https://openalex.org/C2779649592","wikidata":"https://www.wikidata.org/wiki/Q2655970","display_name":"Acetyltransferase","level":4,"score":0.34380000829696655},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.33730000257492065},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.30309998989105225},{"id":"https://openalex.org/C203522944","wikidata":"https://www.wikidata.org/wiki/Q288322","display_name":"Autophagy","level":3,"score":0.29420000314712524},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.29179999232292175},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.2759000062942505},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.2563999891281128}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.5c03208","doi":"https://doi.org/10.1021/acs.jmedchem.5c03208","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.5c03208","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:41656736","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41656736","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7740669250488281,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1992902970","https://openalex.org/W2023457181","https://openalex.org/W2029873534","https://openalex.org/W2032859562","https://openalex.org/W2094070569","https://openalex.org/W2099604646","https://openalex.org/W2104495322","https://openalex.org/W2109054128","https://openalex.org/W2134210799","https://openalex.org/W2168001629","https://openalex.org/W2303090173","https://openalex.org/W2317176158","https://openalex.org/W2563559130","https://openalex.org/W2891213440","https://openalex.org/W2895598897","https://openalex.org/W2905431641","https://openalex.org/W3003883396","https://openalex.org/W3043624656","https://openalex.org/W3205707724","https://openalex.org/W4206662285","https://openalex.org/W4367397036","https://openalex.org/W4379599831","https://openalex.org/W4391824599","https://openalex.org/W4393071288","https://openalex.org/W4399205824","https://openalex.org/W4401116935","https://openalex.org/W4402099650"],"related_works":[],"abstract_inverted_index":{"Using":[0],"our":[1,72],"proprietary":[2],"AI/ML":[3],"platform":[4],"AURIGIN":[5],"that":[6,17,86,134],"maps":[7],"tumor":[8,43],"cells":[9,23],"against":[10],"normal":[11],"developmental":[12],"pathways,":[13],"we":[14,70,122],"identify":[15],"targets":[16],"have":[18],"been":[19],"hijacked":[20],"by":[21,131],"cancerous":[22],"to":[24],"maintain":[25],"a":[26,39,47,83],"highly":[27],"plastic":[28],"proliferative":[29],"cell":[30,44,60,98],"state.":[31],"We":[32],"identified":[33],"the":[34,117],"histone":[35],"acetyltransferase":[36],"KAT2A":[37,107],"as":[38,58],"key":[40],"driver":[41],"of":[42,49,74,77,89,92,106,119,128,139],"plasticity":[45],"in":[46,80,100,108,141],"subset":[48],"acute":[50],"myeloid":[51],"leukemias":[52],"(AML)":[53],"and":[54,64,95,102],"neuroendocrine":[55,65],"carcinomas":[56],"such":[57],"small":[59],"lung":[61],"cancer":[62,67],"(SCLC)":[63],"prostate":[66],"(NEPC).":[68],"Herein,":[69],"describe":[71],"development":[73],"heterobifunctional":[75],"degraders":[76,127],"KAT2A/B,":[78,129],"resulting":[79],"compound":[81,120,132],"7,":[82,121],"picomolar":[84],"degrader":[85],"is":[87],"capable":[88],"inhibiting":[90],"proliferation":[91],"AML":[93],"(MOLM-13)":[94],"SCLC":[96],"(NCI\u2013H1048)":[97],"lines":[99],"vitro":[101],"demonstrates":[103],"robust":[104],"degradation":[105],"NCI\u2013H1048":[109],"engrafted":[110],"mice":[111],"when":[112],"administered":[113],"IP.":[114],"Building":[115],"on":[116],"success":[118],"subsequently":[123],"developed":[124],"orally":[125],"bioavailable":[126],"exemplified":[130],"24,":[133],"achieved":[135],"an":[136],"oral":[137],"bioavailability":[138],"47%":[140],"mice.":[142]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2026-02-10T00:00:00"}